Transarterial Chemoembolization, Transarterial Chemotherapy, and Intra-arterial Chemotherapy for Hepatocellular Carcinoma Treatment
- 1 April 2010
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 37 (2) , 89-93
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Impact of evidence‐based medicine on the treatment of patients with unresectable hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2010
- Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting CriteriaJournal of Vascular and Interventional Radiology, 2009
- Evidence-based diagnosis and locoregional therapy for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology, 2008
- Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized StudiesCardioVascular and Interventional Radiology, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- The Barcelona approach: Diagnosis, staging, and treatment of hepatocellular carcinomaLiver Transplantation, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002